Logo image of ZTR

VIRTUS TOTAL RETURN FUND INC (ZTR) Stock Fundamental Analysis

NYSE:ZTR - New York Stock Exchange, Inc. - US92835W1071 - Currency: USD

5.97  -0.03 (-0.5%)

After market: 5.97 0 (0%)

Fundamental Rating

2

ZTR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ZTR has a bad profitability rating. Also its financial health evaluation is rather negative. ZTR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ZTR had negative earnings in the past year.
In the past year ZTR had a positive cash flow from operations.
In multiple years ZTR reported negative net income over the last 5 years.
Of the past 5 years ZTR 4 years had a positive operating cash flow.
ZTR Yearly Net Income VS EBIT VS OCF VS FCFZTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

Industry RankSector Rank
ROA -4.36%
ROE -6.29%
ROIC 1.18%
ROA(3y)-0.2%
ROA(5y)1.06%
ROE(3y)-0.36%
ROE(5y)1.44%
ROIC(3y)1.22%
ROIC(5y)1.17%
ZTR Yearly ROA, ROE, ROICZTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

1.3 Margins

In the last couple of years the Operating Margin of ZTR has declined.
ZTR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 34.01%
PM (TTM) N/A
GM 34.79%
OM growth 3Y-15.92%
OM growth 5Y-10.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.61%
GM growth 5Y-10.37%
ZTR Yearly Profit, Operating, Gross MarginsZTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200 300

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, ZTR has about the same amount of shares outstanding.
ZTR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ZTR has a worse debt to assets ratio.
ZTR Yearly Shares OutstandingZTR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ZTR Yearly Total Debt VS Total AssetsZTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

ZTR has an Altman-Z score of 1.18. This is a bad value and indicates that ZTR is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of ZTR is 2.31, which is a good value as it means it would take ZTR, 2.31 years of fcf income to pay off all of its debts.
ZTR has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
Even though the debt/equity ratio score it not favorable for ZTR, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 2.31
Altman-Z 1.18
ROIC/WACCN/A
WACCN/A
ZTR Yearly LT Debt VS Equity VS FCFZTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

ZTR has a Current Ratio of 2.10. This indicates that ZTR is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 2.10 indicates that ZTR has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 2.1
ZTR Yearly Current Assets VS Current LiabilitesZTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

3

3. Growth

3.1 Past

The earnings per share for ZTR have decreased strongly by -592.94% in the last year.
ZTR shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.39%.
The Revenue has been growing by 9.32% on average over the past years. This is quite good.
EPS 1Y (TTM)-592.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%110.52%
Revenue 1Y (TTM)38.39%
Revenue growth 3Y9.15%
Revenue growth 5Y9.32%
Sales Q2Q%36.35%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZTR Yearly Revenue VS EstimatesZTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
ZTR Yearly EPS VS EstimatesZTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZTR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZTR Price Earnings VS Forward Price EarningsZTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 4.55
EV/EBITDA N/A
ZTR Per share dataZTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.17%, ZTR is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.28, ZTR pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.17%

5.2 History

The dividend of ZTR decreases each year by -6.15%.
ZTR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-6.15%
Div Incr Years0
Div Non Decr Years0
ZTR Yearly Dividends per shareZTR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of ZTR are negative and hence is the payout ratio. ZTR will probably not be able to sustain this dividend level.
DP-221.06%
EPS Next 2YN/A
EPS Next 3YN/A
ZTR Yearly Income VS Free CF VS DividendZTR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

VIRTUS TOTAL RETURN FUND INC

NYSE:ZTR (2/4/2025, 8:17:47 PM)

After market: 5.97 0 (0%)

5.97

-0.03 (-0.5%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)02-03 2025-02-03
Earnings (Next)N/A N/A
Inst Owners31.84%
Inst Owner Change8.61%
Ins Owners0.01%
Ins Owner Change0%
Market Cap368.47M
Analysts45
Price TargetN/A
Short Float %0.51%
Short Ratio0.94
Dividend
Industry RankSector Rank
Dividend Yield 9.17%
Yearly Dividend0.87
Dividend Growth(5Y)-6.15%
DP-221.06%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-13 2025-03-13 (0.05)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.61
P/FCF 4.55
P/OCF 4.55
P/B 0.86
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.31
FCFY21.98%
OCF(TTM)1.31
OCFY21.98%
SpS0.44
BVpS6.95
TBVpS6.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.36%
ROE -6.29%
ROCE 1.49%
ROIC 1.18%
ROICexc 1.18%
ROICexgc 1.18%
OM 34.01%
PM (TTM) N/A
GM 34.79%
FCFM 299.08%
ROA(3y)-0.2%
ROA(5y)1.06%
ROE(3y)-0.36%
ROE(5y)1.44%
ROIC(3y)1.22%
ROIC(5y)1.17%
ROICexc(3y)1.22%
ROICexc(5y)1.17%
ROICexgc(3y)1.22%
ROICexgc(5y)1.17%
ROCE(3y)1.54%
ROCE(5y)1.48%
ROICexcg growth 3Y-8.98%
ROICexcg growth 5Y-8.56%
ROICexc growth 3Y-8.98%
ROICexc growth 5Y-8.38%
OM growth 3Y-15.92%
OM growth 5Y-10.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.61%
GM growth 5Y-10.37%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 2.31
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.79
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 2.1
Altman-Z 1.18
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-592.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%110.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)38.39%
Revenue growth 3Y9.15%
Revenue growth 5Y9.32%
Sales Q2Q%36.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.72%
EBIT growth 3Y-8.22%
EBIT growth 5Y-2.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y156.73%
FCF growth 3Y3.51%
FCF growth 5Y0.42%
OCF growth 1Y156.73%
OCF growth 3Y3.51%
OCF growth 5Y0.42%